𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-standing paraphilia induced by dopamine agonists in Parkinson's disease

✍ Scribed by Fanny Pineau; Michael Schüpbach; Jean-Christophe Corvol; Constance Flamand-Rouvière; Marie Vidailhet; Emmanuel Roze

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
273 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

We appreciate the careful reading of our manuscript by Okun and colleagues. 1 However, their letter contains a number of inaccuracies that require correction. We clearly state

📜 SIMILAR VOLUMES

Dopamine agonist-induced antecollis in P
Dopamine agonist-induced antecollis in Parkinson's disease
✍ Akiyuki Uzawa; Masahiro Mori; Shigeyuki Kojima; Satsuki Mitsuma; Yukari Sekiguch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 1 views

## Abstract Few cases of dopamine agonist‐induced antecollis in Parkinson's disease (PD) have been reported. Literature review of 16 PD patients including our 3 cases with dopamine agonist‐induced antecollis showed predominance of (1) Japanese, (2) women, and (3) Hoehn‐Yahr stage of ≥3. We experien

Hiccup secondary to dopamine agonists in
Hiccup secondary to dopamine agonists in Parkinson's Disease
✍ Jacobo Lester; Gabriela Beatriz Raina; Claudia Uribe-Roca; Federico Micheli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

Hiccup is produced by a sudden contraction of the inspiratory muscles followed by an abrupt closure of the glottis, which produces the typical sound that characterizes this disorder. The causes of hiccup are diverse, 1 including several drugs. 2 Here, we report two cases of patients with Parkinson's

Long-term tolerability and efficacy of c
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
✍ R. Inzelberg; P. Nisipeanu; M. J. Rabey; Prof. A. D. Korczyn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

## Abstract Motor fluctuations constitute a severe complication of chronic levodopa therapy. The addition of dopamine agonists may partially alleviate these responses; however, due to the short half‐lefe of these drugs, several daily doses are required. Cabergoline is a new dopamine agonist with a